Cybrexa, Inc.

5 Marks

Corp.

First Filed:Jan 26, 2017Latest Filed:Oct 20, 2022Address:5 Science Park, New Haven, CT 06511

Portfolio Overview

Registered

3(60%)

Pending

1(20%)

Dead

1(20%)

Top Classes

Class 42

Software, IT Services & Scientific Research

3(60%)

Class 5

Pharmaceuticals

2(40%)

TTAB Proceedings

No litigation activity

Top Firms

SHIPMAN & GOODWIN LLP(Oct 2022)

Trademark Portfolio

5 results

(current & previous marks)

Refine by Mark/Description🔽

Filed

Registered

Last Activity

Filters

Ownership

Current5

Previous0

Status

Registered3

Pending1

Cancelled0

Abandoned1

Expired0

Mark Type

Word4

Stylized0

Design0

Combined1

NonVisual0

Class 52

Class 423

ALPHALEX

Trademark

Word

PENDING

Owner:

Serial:97640497

Filed:Oct 20, 2022

Classes:5

Goods & Services

Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment